Loading

Annals of Psychiatry and Mental Health

Gender Differences in Juvenile Attention-Deficit or Hyperactivity Disorder

Review Article | Open Access

  • 1. Clinical Psychology at the Illinois School of Professional Psychology, Argosy University, USA
+ Show More - Show Less
Corresponding Authors
Robert Eme, Illinois School of Professional Psychology, 1000 N. Plaza Drive, Schaumburg IL, USA, Tel: 847.969.4943; Fax 847.969.4943
Abstract

Attention-Deficit/Hyperactivity Disorder (ADHD), a disorder characterized by significant problems with attention, impulsiveness and excessive activity, is one of the most prevalent childhood psychiatric disorders and one of the most common reasons why juveniles with behavior problems are referred to health service providers.

Citation

Eme R (2017) Gender Differences in Juvenile Attention-Deficit/Hyperactivity Disorder. Ann Psychiatry Ment Health 5(3): 1103.

Keywords

•    Attention-Deficit/Hyperactivity Disorder
•    Comorbidity
•    Stress

INTRODUCTION

Attention-Deficit/Hyperactivity Disorder (ADHD), a disorder characterized by significant problems with attention, impulsiveness and excessive activity, is one of the most prevalent childhood psychiatric disorders and one of the most common reasons why juveniles with behavior problems are referred to health service providers [1]. Although ADHD was believed to only be a male disorder for much of the 20th century, it is now clearly accepted that females can have the disorder [2]. For example, in the United States approximately 6.2% of girls (14.1% boys) between the ages of 5-17 have been diagnosed with ADHD according to parental report. With this recognition has come a consideration of what, if any, are the gender differences in ADHD. This short communication will address this issue by summarizing the findings on gender differences in juveniles in the categories that have received the most research attention: prevalence, symptoms, outcomes, and treatment.

Prevalence

Gender differences in prevalence can be considered in terms of overall prevalence rate and prevalence rate in subtypes. Regarding overall prevalence, a highly reliable finding is that in childhood males outnumber females by approximately 3:1 in the general population, and by ratios as high as 9:1 in clinic populations, with this difference diminishing in adults [2,3]. It is thought that the most likely reason for the much higher clinic ratio is that boys with ADHD are more likely than girls to develop disruptive behavior problems which motivate parents and teachers to seek help [2,3]. Although the reason (s) for the greater male prevalence in the general population are not completely known, two plausible explanations are the slower brain development in boys and the greater male vulnerability to a host of pre- and peri-natal problems such as preterm birth which have been linked to the development of ADHD [2,4,5]. The attenuation of the sex difference in adulthood may be due to two factors [2]. Regarding general population prevalence, the difference may attenuate because delayed maturation, which can be a cause of ADHD and which is more common in males, is lessened. Regarding prevalence in clinical populations, since referral is self-motivated (not parental motivated as in childhood) and women are more likely to seek help for a variety of problems (including those that are ADHD-related), women are as likely, if not more likely, to self-refer.

Regarding subtype prevalence, again a distinction needs to be made between general and clinical populations. Although the findings are less clear than those of overall prevalence, it appears that there is gender equivalence in subtype rates in the general population. However, in clinic populations, boys are more likely to present with the combined subtype than the inattentive subtype, whereas girls are more likely to present with the inattentive subtype [2,6]. Again, the most likely reason for this difference is that boys with the predominantly hyperactive/impulsive type of presentation of ADHD are also more likely to be have comorbid disruptive behavior problems precipitated, in part, by their hyperactive/ impulsive symptoms thereby prompting parents and teachers to seek help.

Symptoms

Once it became recognized that girls can have ADHD, questions were raised regarding whether there were differences in the ways the genders expressed the symptoms of ADHD. Overall, ADHD rating scales are psychometrically equivalent for boys and girls, and there is little evidence for sex-specific expression of ADHD symptoms [2,6]. However, boys make exhibit more severe ADHD symptoms [7]. In addition, girls may tend to be more hyper verbal than boys and a girl’s impulsivity may also be more verbal than behavioral [2,6]. For example, a highly impulsive girl may be less likely than a boy to run out into traffic but more likely to pick the first answer on a multiple choice test [6].

Outcomes

In marked contrast to the paucity of search on sex-specific ADHD symptoms (which accounts for the brevity of the prior discussion), there is a rather ample amount of research on the outcomes of ADHD. This research can be classified into three domains: persistence of symptoms and diagnostic status, comorbidity, and functional outcomes.

Persistence of Symptoms and Diagnostic Status

Although ADHD was once believed to be a transient childhood problem, it is now widely recognized that many cases persist into adolescence and adulthood. Thus, research has found that of all children with ADHD, 45%-85% continue to show symptoms into adolescence while 50%-60% continue to show symptoms into adulthood with the most recent findings coming from the Multimodal Treat Study of ADHD (MTA). This study 579 children (465 males) diagnosed with combined type ADHD at ages 7-9 is the largest longitudinal study to date with the most representative, generalizable clinical sample of children with ADHD in the United States [8]. In the most recent follow-up of 453 of the participants at a mean age of 25 years 50% of the participants had persistent ADHD based upon DSM-5 criteria as assessed by self-report [9]. There were no gender differences in rates of persistence. This finding coheres with the overall finding of few known gender differences in the developmental progression of ADHD from childhood to adulthood [2].

Comorbidity

Comorbidity has been examined most extensively in the externalizing domain, e.g. conduct disorder (CD), and the internalizing domain, e.g., anxiety. Adolescent and adulthood outcomes in the externalizing domain have been well researched and the major finding is that ADHD is a risk factor for externalizing problems at all ages for both genders [2]. For example, meta-analyses have reported odds ratios for comorbid CD for children with ADHD compared to those without ADHD of 10.7 for boys and 9.4 for girls, with boys however more likely than females to develop more severe externalizing problems such as physical aggression in childhood, and violence and substance abuse in adolescence [10-12]. Despite comparable levels of greatly increased relative risk for boys and girls compared to their non-ADHD peers, it is not likely that this increased risk results in equivalent rates of comorbid externalizing problems for boys and girls with childhood ADHD since boys in general have higher rates for externalizing problems, regardless of ADHD status [5]. However, since data based upon parental report yields equivalent rates of externalizing problems in contrast to the much lower female rate reported in a study using objective observational data, somewhat surprisingly, the “jury is still out” on this issue[2]. Lastly, conduct problems, the most often identified predictor of problematic adult outcome in boys with ADHD, also predict overall worse functioning in adulthood for females [13].

Regarding the risk ADHD poses for problems in the internalizing domain, although the evidence is less robust than it is for externalizing problems, it does appear that childhood ADHD increases risk for internalizing problems in adolescence for both sexes, with the risk being somewhat stronger for girls than boys [2]. Most recently, the increased risk for internalizing problems is perhaps most strikingly evident for non-suicidal self-injury as indicated by the findings in the Berkeley Girls with ADHD Longitudinal Study [14]. At an average age of 19.6 the rates for engaging in non-suicidal self-injury for girls with childhood ADHD were 51% (ADHD-combined presentation), 29% (ADHD-predominantly inattentive presentation), and 19% (comparison group). In addition, it should be noted girls generally have higher rates of internalizing problems than boys, regardless of ADHD status [2]. Lastly, despite the high rate of comorbid anxiety disorders (37.7%) compared to the lower rate of comorbid conduct disorder (12.8%) for girls with ADHD, the relative odds of having these comorbidities when compared to girls without ADHD are much higher for conduct disorder (9.4) than for an anxiety disorder (3.2) [2]. This large difference in relative odds also occurs in boys with ADHD compared to their non-ADHD peers (10.7, conduct disorder; 3.0, anxiety) [10]. This finding of a large odds ratio difference between conduct problems and anxiety problems for girls is especially important since girls who are clinic referred for ADHD, in contrast to boys who are clinic referred for ADHD, are often only treated for their internalizing symptoms, even when externalizing symptoms are obviously present [12].

Functional Outcomes

Children with ADHD compared to their non-ADHD peers are more likely to develop impairments in virtually every domain that has been measured, e.g., academic, occupational, social, driving [2,15]. Overall, boys and girls experience the same level of risk of impairment in the various domains, with perhaps boys having more trouble in school than girls, especially with behavior as opposed to academic achievement [2].

TREATMENT

The literature is quite clear in finding that boys and girls have an equivalent response to treatment for ADHD [2]. The clearest evidence comes from The Multimodal Treat Study of ADHD (MTA) of 579 children (465 males) diagnosed with combined type ADHD at ages 7-9 as it is the largest study to date with the most representative, generalizable clinical sample of children with ADHD (McGough, 2016). The goal of the study was to investigate the relative success of four treatment strategies to which the children were randomly assigned: behavioral treatment, medication management, treatment combining behavior and medication management, and typical community as-usual treatment (most of whom were treated with medication (MTA, 1999, Connor). At the 14-month outcome, both the medication management and combined management showed significant improvement in ADHD symptoms, and both were superior to behavior management alone and community treatment as usual ((MTA, 1999, Connor). Overall, there were no significant gender differences in the response to treatment (Owens 2003). Similarly, and most recently, a study of behavioral treatments of children with ADHD- inattentive type (58% boys) found that the treatments worked equally well for boys and girls. The authors also noted that this result was consistent with findings from prior studies of medical and behavioral treatments for ADHD (Owens 2016). In short, the literature has consistently failed to find and gender differences in treatment response for either the combined type or predominantly-inattentive type of ADHD.

CONCLUSION

Now that the reality of female ADHD has finally been clearly recognized, the big picture conclusion is that girls generally do not show unique symptoms, correlates, or outcomes. In short, ADHD is a serious, debilitating, persistent disorder for both genders with the similarities far outweighing the differences. Although girls with ADHD may be at higher risk for internalizing disorders than boys with ADHD, who may show a higher risk for externalizing disorders, these gender differences are the same as those seen in the general population and therefore are not specific to ADHD. The overall conclusion of a lack of gender differences in juvenile ADHD notwithstanding, two important findings related to externalizing and internalizing problems should not be overlooked. First, girls with ADHD compared to their non-ADHD peers are at much higher relative risk for having a conduct disorder than an anxiety disorder. Second, in the internalizing domain, special attention should be given to evaluating for non-suicidal self-injury in girls with ADHD.

REFERENCES

1. Barkley R. History of ADHD. In Barkley, R., editor. Attention-Deficit/ Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 4th ed. Guilford Press, 2015.

2. Owens E, Cardoos S, Hinshaw S. Developmental progression and gender differences in individuals with ADHD. In Barkley, R., editor. Attention-Deficit/Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 4th ed. Guilford Press, 2015.

3. Swanson J, Lakes K, Wigal T, Volkow N. Multiple origins of sex differences in Attention-Deficit/Hyperactivity Disorder. In Plaff, D., & Christen, Y., editors. Multiple Origins of Sex Differences in the Brain. Springer-Verkagm, 2013.

4. Sucksdorff M, Lehtonen L, Chudal R, Suominen A, Joelsson P, Gissler M, et al. Preterm Birth and Poor Fetal Growth as Risk Factors of Attention-Deficit/ Hyperactivity Disorder. Pediatrics. 2015; 136: 599-608.

5. Eme R. Sex differences in the prevalence and expression of externalizing behavior. In Beauchaine, T., & Hinshaw, S., editors, The Oxford Handbook of Externalizing Spectrum Disorders. Guilford Press. 2015.

6. Hinshaw S, Ellison K. ADHD: What Everyone Need to Know. Oxford University Press, 2016.

7. Arnett AB, Pennington BF, Willcutt EG, DeFries JC, Olson RK. Sex differences in ADHD symptom severity. J Child Psychol Psychiatry. 2015; 56: 632-639.

8. McGough, J. New insights from the MTA: Who outgrows Attention-Deficit/Hyperactivity Disorder and what becomes of those who don t?. Journal of the American Academy of Child and Adolescent Psychiatry. 2016; 55: 925-926.

9. Roy A, Hechtamn L, Arnold L, Sibley M, Molina B, Swanson J, Howard A. Childhood factors affecting persistence and desistence of Attention-Deficit/Hyperactivity Disorder symptoms in adulthood: Results from MTA study. Journal of the American Academy of Child and Adolescent Psychiatry. 2016; 55: 937- 945.

10. Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry. 1999; 40: 57-87.

11. Hinshaw S. Preadolescent girls with attention-deficit/hyperactivity disorder. I. Background characteristics, comorbidity, cognitive functioning, and parenting practices. Journal of Consulting and Clinical Psychology. 2002; 70: 1086-1098.

12. Tung I, Li JJ, Meza JI, Jezior KL, Kianmahd JS, Hentschel PG, et al. Patterns of Comorbidity Among Girls With ADHD: A Meta-analysis. Pediatrics. 2016; 138: 20160430.

13. Owens EB, Hinshaw SP. Childhood conduct problems and young adult outcomes among women with childhood attention-deficit/ hyperactivity disorder (ADHD). J Abnorm Psychol. 2016; 125: 220- 232.

14. Hinshaw S. Self-harm as a developmental outcome in girls with ADHD. The ADHD Report. 2015; 23:1-6.

15. Hechtman L, Swanson J, Sibley M, Stehli A, Owens E, Mitchell J, et al. Functional adult outcomes 16 years after childhood diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA results. Journal of the American Academy of Child and Adolescent Psychiatry. 2016; 55: 945- 960.

Eme R (2017) Gender Differences in Juvenile Attention-Deficit/Hyperactivity Disorder. Ann Psychiatry Ment Health 5(3): 1103.

Received : 12 Apr 2017
Accepted : 03 May 2017
Published : 05 May 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X